Figure 1
Figure 1. GST-Gi2α pulldown of RGS18 from human platelet lysates. Human platelets. (A) Lysates were prepared from resting platelets and from platelets incubated with forskolin (20 µM), PGI2 (15 µM), or the PAR1 agonist peptide, SFLLRN (50 µM). The lysates were then incubated with GST-Gi2α coupled to glutathione beads in the presence of GDP plus AlF4− or GDP alone as indicated. Bound proteins were subjected to electrophoresis and probed with RGS18 and Gi2α antibodies to detect RGS18 and GST-Gi2α fusion protein, respectively. (B) Summary of 3 experiments expressed as the percentage of the result obtained with resting platelets (mean ± SEM). P values are relative to resting platelets. IB, immunoblotting.

GST-Gi2α pulldown of RGS18 from human platelet lysates. Human platelets. (A) Lysates were prepared from resting platelets and from platelets incubated with forskolin (20 µM), PGI2 (15 µM), or the PAR1 agonist peptide, SFLLRN (50 µM). The lysates were then incubated with GST-Gi2α coupled to glutathione beads in the presence of GDP plus AlF4 or GDP alone as indicated. Bound proteins were subjected to electrophoresis and probed with RGS18 and Gi2α antibodies to detect RGS18 and GST-Gi2α fusion protein, respectively. (B) Summary of 3 experiments expressed as the percentage of the result obtained with resting platelets (mean ± SEM). P values are relative to resting platelets. IB, immunoblotting.

Close Modal

or Create an Account

Close Modal
Close Modal